Phase 1 Study of Trametinib and Neoadjuvant Chemoradiation (CRT) in Locally Advanced Rectal Cancer (LARC) with KRAS, BRAF, or NRAS Mutations

Autor: Wuthrick, E.J., Williams, T.M., Wei, L., Umar, H., Savysan, A., Mikhail, S., Ciombor, K., Noonan, A., Roychowdhury, S., El-Dika, S., Krishna, S., Upchurch, B., Arnold, M., Harzman, A., Abdel-Misih, S., Cirocco, W., Bekaii-Saab, T., Wu, C.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2016 96(2) Supplement:S107-S108
Databáze: ScienceDirect